- Home
- IMMP vs TLS Comparison
IMMP vs TLS Comparison
Compare IMMP & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- TLS
- Stock Information
- Founded
- IMMP 1987
- TLS 1969
- Country
- IMMP Australia
- TLS United States
- Employees
- IMMP N/A
- TLS N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- TLS EDP Services
- Sector
- IMMP Health Care
- TLS Technology
- Exchange
- IMMP Nasdaq
- TLS Nasdaq
- Market Cap
- IMMP 304.0M
- TLS 249.0M
- IPO Year
- IMMP N/A
- TLS 2020
- Fundamental
- Price
- IMMP $1.93
- TLS $3.31
- Analyst Decision
- IMMP Buy
- TLS Buy
- Analyst Count
- IMMP 2
- TLS 5
- Target Price
- IMMP $8.50
- TLS $4.50
- AVG Volume (30 Days)
- IMMP 98.7K
- TLS 304.0K
- Earning Date
- IMMP 02-27-2025
- TLS 03-14-2025
- Dividend Yield
- IMMP N/A
- TLS N/A
- EPS Growth
- IMMP N/A
- TLS N/A
- EPS
- IMMP N/A
- TLS N/A
- Revenue
- IMMP $2,563,302.00
- TLS $122,959,000.00
- Revenue This Year
- IMMP N/A
- TLS N/A
- Revenue Next Year
- IMMP $47.79
- TLS $38.31
- P/E Ratio
- IMMP N/A
- TLS N/A
- Revenue Growth
- IMMP 9.59
- TLS N/A
- 52 Week Low
- IMMP $1.66
- TLS $1.89
- 52 Week High
- IMMP $3.34
- TLS $5.03
- Technical
- Relative Strength Index (RSI)
- IMMP 42.28
- TLS 47.47
- Support Level
- IMMP $2.00
- TLS $3.22
- Resistance Level
- IMMP $2.05
- TLS $3.35
- Average True Range (ATR)
- IMMP 0.09
- TLS 0.18
- MACD
- IMMP -0.02
- TLS -0.00
- Stochastic Oscillator
- IMMP 8.33
- TLS 51.85
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About TLS Telos Corporation
Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.